“…Fittingly, hypomorphic XBP1 variants confer genetic risk for both forms of IBD, Crohn's disease and ulcerative colitis (Kaser et al, 2008). Additional genetic risk factors that impact the UPR have been discovered in IBD (e.g., ORMDL3 [McGovern et al, 2010] and AGR2 [Zheng et al, 2006]), and in some cases their genetic deletion in mice can lead to spontaneous IBD-like disease as well (Zhao et al, 2010). Notably, it appears that IECs in IBD generally experience unresolved ER stress, even in the absence of overt tissue-destructive inflammation (Heazlewood et al, 2008;Kaser et al, 2008;Tréton et al, 2011), with the effectiveness of the UPR being under the influence of primary (genetic) and secondary (environmental) factors (Kaser and Blumberg, 2011).…”